IFNG and psoriasis: Serum angiogenesis‐related VEGF‐A; Th1‐related IFN‐γ and Th2‐related DEFB2 serum expression levels remained significantly higher in patients with moderate‐to‐severe psoriasis after secukinumab treatment than in normal subjects.